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Abstract 11 
Three milk products, skim milk powder (SMP), demineralised whey powder (DWP) and a 12 
whey dominant infant formula (60/40IF) and their corresponding partially hydrolysed 13 
products (SMPhyd, DWPhyd and 60/40hyd, respectively) were subjected to static infant in 14 
vitro gastro-intestinal (GI) digestion and their digesta were subsequently analysed for protein 15 
breakdown. The pre-hydrolysis of proteins provided a head-start in the gastric digestion 16 
process compared to the intact proteins, resulting in a higher proportion of small peptides (<1 17 
kDa), a higher degree of hydrolysis and lower observable protein coagulation or curd 18 
formation in the gastric phase of the casein dominant systems in particular, which may lead to 19 
an earlier onset of gastric emptying in vivo. Little or no differences were detected during the 20 
intestinal phase. Hence pre-hydrolysis of proteins may be used as a strategy to lower gastric 21 
transit times which may ease the gastric digestion of infant formulations. 22 
 23 
1. Introduction  24 
Human milk is considered the nutritional gold standard for the newborn as it is tailored for 25 
the needs of the infant. In cases where the infant is not breast-feed it is important to provide 26 
infant formulas (IF) of the highest quality for adequate growth and development and the 27 
composition of these foods are strictly regulated (Codex-Alimentarius, 1987). Delivery of 28 
quality proteins that match the amino acid profile of human milk is to date mostly ensured by 29 
the formulation of bovine protein fractions, namely skim milk combined with whey protein 30 
concentrate from whey, a high quality protein by-product of cheese or casein production. 31 
First stage IF is designed to be the sole food for infants, hence whey protein based formulas 32 
have come to dominate the market place owing to the high nutritional value of whey proteins 33 
as well as their greater similarity to human milk when compared to casein based IF. The 34 
protein ratio of caseins to whey proteins in IF at 40:60, is similar to human milk but different 35 
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to bovine milk which has an 80:20 ratio. It is thought that the lower levels of casein in both 36 
first stage IF and breast milk in comparison to bovine milk allows for faster gastric transit due 37 
to the formation of a softer curd during the gastric phase, leading to faster and easier gastro-38 
intestinal (GI) digestion (Thompkinson & Kharb, 2007). The protein content in IF has also 39 
been lowered to mimic more closely the total protein levels found in human milk and 40 
eliminate excess levels of amino acids thought to cause metabolic stress in the infant (Fomon, 41 
1991; Raiha, 1994). Second stage IF or Follow up Formula (FUF) typically contains a greater 42 
proportion of casein than first stage and mimics the protein profile of late stage breast milk 43 
(Kunz & Lonnerdal, 1992). Skim milk is typically added to infant formula to provide the 44 
casein element of the formula with whey, often in the form of whey protein isolate or other 45 
enriched whey components added to provide the majority of the whey protein (Schuck, 46 
Blanchard, & Zhu, 2013) 47 
In contrast to plant based materials the main protein constituents of milk i.e. casein and whey 48 
proteins are readily digested by the human GI system. It would appear that the caseins have a 49 
longer residence time in the gastric phase than the whey proteins and this can be related to the 50 
coagulation of the caseins at their isoelectric point in the stomach by the action of gastric HCl 51 
(Mulet-Cabero, Mackie, Wilde, Fenelon, & Brodkorb, 2019; Mulet-Cabero, Rigby, 52 
Brodkorb, & Mackie, 2020). The exact mechanism and degree to which this governs slower 53 
gastric emptying of casein relative to whey protein into the duodenum is not clear. However, 54 
it is known that casein empties from the stomach in the form of degraded peptides whereas 55 
the whey proteins and β-lactoglobulin (β-lg) in particular, enter the duodenum as intact 56 
protein (Mahé, et al., 1996). Processing of milk is also known to affect the gastric curd, 57 
which is formed upon acidification and digestion by pepsin. Raw and pasteurised milk was 58 
shown to form a harder more compressed curd during semi-dynamic (Mulet-Cabero, et al., 59 
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2019) as well as dynamic (Ye, Cui, Dalgleish, & Singh, 2016; Ye, et al., 2019) in vitro 60 
digestion compared to that of heated UHT milk. This was explained by the denaturation of 61 
the whey proteins and their association with the caseins during heat treatment as well as a re-62 
distribution of calcium within the casein micelle, which affects the proteolysis by pepsin and 63 
the curd formation. 64 
There are two main types of in vitro methods, static and dynamic; in static methods the food 65 
is subjected to preset physiological digestion parameters set to emulate the conditions found 66 
in the oral, gastric and intestinal phase. Although more accurate, the dynamic digestion 67 
methods which simulate the gradual addition of digestive fluids as well as continous gastric 68 
emptying into the intestinal tract are relatively complex, expensive to run, often commercially 69 
operated hence not standardised, and commonly unavailable to the majority of food 70 
researchers. Hence most published digestion studies use simpler static methods. To overcome 71 
the shortcomings such as variations in physiological conditions i.e. enzyme activities, 72 
dilutions and pH, of the different static models present at the time an international group of 73 
experts agreed to a consensus model for adult static in vitro digestion (Brodkorb, et al., 2019; 74 
Minekus, et al., 2014) also known as the INFOGEST method. However, no such consensus 75 
exists for different population groups (Levi, et al., 2017). For simulating infant digestion, the 76 
most commonly used static infant in vitro method is by Dupont et al., (2010) , which was 77 
further refined and aligned with some aspects of the INFOGEST method by Menard et al. 78 
(2018). 79 
The objective of this study was to assess the effect of pre-digestion of proteins, i.e. partial 80 
hydrolyses of the proteins in skim milk (SM), Demineralised Whey Protein (DWP) and a 81 
60/40 ratio whey protein/casein mix (60/40IF) representing a model first-stage IF, on their 82 
digestive behaviour in vitro and compare this to existing evidence in vivo. 83 
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 84 
2. Materials and methods 85 
2.1 Materials. 86 
Six powder samples containing varying amounts of casein and whey proteins were provided 87 
by Kerry Group (Naas, Co. Kildare, Ireland). One group consisted of un-hydrolysed Skim 88 
Milk Powder (SMP), De-mineralised Whey Powder (DWP) and a whey dominant infant 89 
formula blend containing 60/40 whey protein to casein ratio (60/40IF). The second group 90 
consisted of the same set of powders, which had been partially hydrolysed (Degree of 91 
hydrolysis (DH): DWPhyd, 12.6%; SMPhyd, 12.2%, 60/40hyd a mixture of DWPhyd and 92 
SMPhyd, figures provided by Kerry Group). Compositional analysis was carried out in-house 93 
by the Moorepark Technical Service (Table 1). The protein content was determined by the 94 
Kjeldahl method (Bradstreet, 1954; Kjeldahl, 1883) using a nitrogen conversion factor (NCF) 95 
of 6.38 (Jones, 1931). The fat content was determined by the Rose Gottlieb method (AOAC, 96 
Arlington, USA, 1980). The moisture and ash were determined by gravimetric oven from 97 
LECO (LECO Instruments, Stockport, United Kingdom). 98 
Each of the samples was prepared to 2% (w/w) protein and rehydrated overnight at 4ºC 99 
before being stirred for 2 hours at ambient temperature prior to digestion. Three independent 100 
sets of protein solutions were prepared for the experiments (n=3). All salts for the Simulated 101 
Gastric Fluid (SGF) and Simulated Intestinal Fluid (SIF) were prepared using analytical 102 
grade chemicals supplied by Sigma-Aldrich (Sigma Chemical Co. St. Louis, USA). Rabbit 103 
Gastric Extract (RGE) was supplied by Lipolytech (Marseille, France). Pancreatin (P-7545, 104 
SLBV6830) and bile extract (B8631, 031MO106V) and all other reagents were sourced from 105 
Sigma-Aldrich (Sigma Chemical Co. St. Louis, USA) unless stated otherwise. 106 
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 107 
2.2 Methods 108 
2.2.1 In vitro digestion of liquid meals  109 
The food samples which had been re-hydrated overnight on a 2% (w/w) protein basis were 110 
subjected to both gastric and intestinal digestion according to the scheme of Menard et al. 111 
(2018). This is the most recent in vitro infant digestion model reflecting the latest 112 
physiological data available. For the gastric digestion the samples were collected at time zero, 113 
with no enzyme (G0), after 30 min (G30) and finally after 60 min (G60). The samples for 114 
intestinal digestion were taken after the gastric digestion step was completed for 1h and then 115 
underwent intestinal digestion for either, 15 min (I15), 30 min (I30) or 60 min (I60). The time 116 
points were chosen to reflect the importance of both the gastric and intestinal endpoints and 117 
to allow sufficient time for preparation of the digesta so as to minimise the amount of error in 118 
the replicates. SGF and SIF were prepared and stored at 4ºC and all enzyme solutions were 119 
prepared on the day of the trial and stored on ice. The pancreatin added achieved the trypsin 120 
activity of 16 U/mL of intestinal content and covered the required lipase activity of 90 U/mL 121 
of intestinal content and the RGE added achieved the pepsin activity of 268 U/mL of gastric 122 
contents quoted by Menard et al. (2018). Porcine bile was added to give a final level of 3.1 123 
mM of bile salts and calcium chloride was added separately to give a final intestinal 124 
concentration of 3 mM. The gastric phase was at pH 5.3 and the intestinal phase was at pH 125 
6.6, which is based on available physiological data. For further justification of the infant 126 
digestion parameters, see Menard et al. (2018). All of the solutions were kept at 37ºC prior to 127 
digestion. Sample preparation of the gastric samples G0, G30 and G60 involved the 128 
adjustment of the pH to 7.0, followed by snap-freezing in liquid nitrogen. The digestion of 129 
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the intestinal samples was completed by adding Pefabloc
®
 inhibitor to the samples before 130 
snap-freezing in liquid nitrogen. 131 
2.2.2 Molecular weight distribution 132 
Size Exclusion Chromatography-High Performance Liquid Chromatography (SEC-HPLC) 133 
was carried out to estimate the molecular weight distribution of proteins and digesta, using a 134 
TSK G2000 SWxl column (600  7.5 mm; Tosoh Bioscience GmbH, Stuttgart, Germany), on 135 
a Waters 2695 HPLC with UV/ Visible detector and EMPOWER
®
 software. Separation was 136 
achieved by isocratic elution using 0.1% TFA in 30% acetonitrile. 10μl of 0.25% protein 137 
solutions were filtered through a 0.45 μm PES filter prior to injection onto the column. A 138 
series of molecular weight standards (GE Healthcare, Chicago, IL, USA), were ran on the 139 
SEC to create a calibration curve including bovine serum albumin, carbonic anhydrase, β-lg, 140 
α-lac, aprotinin, insulin chain b, bacitracin, histidine-tyrosine-leucine, phenylalanine and 141 
glycine with molecular weights of 67000, 29000, 18400, 14400, 6500, 3496, 1400, 294, 165 142 
and 75 Da, respectively. Molecular weight intervals were determined according to Gaspard et 143 
al.(2019). 144 
 145 
2.2.3 Estimation of protein digestion  146 
The digested protein/peptide content in the in vitro samples was determined from the soluble 147 
fraction of a 50:50 v/v mixture of sample and 24% (w/v) trichloroacetic acid (TCA) after 148 
centrifugation at 3,000 g for 30 min using the Kjeldahl method using a NCF of 6.38. The 149 
percentage of protein digestion or digestibility was then calculated according to the scheme 150 
of Rudloff et al.(1992) by comparison with the estimated protein in the original digest minus 151 
the amount found in the blank sample, which contained digestive enzyme but no food. 152 
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 153 
 154 
2.2.4 Protein characterisation 155 
Sodium Dodecyl Sulphate Poly-Acrylamide Gel Electrophoresis (SDS-PAGE) of the protein 156 
products and the in vitro digests was carried out using a 4-12% Bis-Tris polyacrylamide gel 157 
(Invitrogen, CA, USA). Samples were prepared under reducing conditions using NUPAGE
®
 158 
sample agent containing ditritheriol (DTT). Samples were heated to 85ºC for 2 min to ensure 159 
unfolding of the proteins. An unstained molecular weight ladder from Invitrogen (Invitrogen, 160 
CA, USA) was also run in two lanes to determine the size of the proteins. The samples were 161 
stained in instant blue stain (Expedeon, Cambs., UK). The gels were de-stained in MilliQ
®
 162 
water before image analysis using an Epson Scanner (Epson-Telford Ltd., Telford, UK). 163 
 164 
2.2.5 Protein hydrolysis 165 
The levels of the free amine groups in the digests were determined by o-phthaldialdehyde 166 
(OPA) 96-well micro-assay using the method of Spellman et al.(2003). A calibration curve 167 
was prepared as described by Mulet-Cabero et al. (2019) from a set of L-leucine standard 168 
solutions between 0-10 mM. 10µL of either the standard or sample was then mixed with 200 169 
µL of OPA for 15 min and the resultant absorbance was measured in a microplate reader 170 
(BioTek Instruments GmbH, Bad Friedrichshall, Germany) at 340nm. 171 
 172 
2.2.6 Statistical analysis 173 
Revised manuscript submitted in Word format to IDJ on July 8, 2020; 
Corrigan, B., & Brodkorb, A. (2020). The effect of pre-treatment of protein ingredients for infant formula on their in vitro 
gastro-intestinal behaviour. International Dairy Journal, 110, 104810. doi:10.1016/j.idairyj.2020.104810 
Page 9 of 32 
All statistical analysis was carried out using Minitab software (Minitab Inc.,PA, USA) with 174 
comparison of the means using Tukey’s model (n=3). 175 
 176 
3. Results 177 
3.1 Visual assessment of digests 178 
SMP, DWP, 60/40IF and their respective hydrolysed products were exposed to in vitro 179 
gastric and intestinal digestion based on the most recent static infant method (Ménard, et al., 180 
2018). The hydrolysed samples DWPhyd and 60/40hyd were largely translucent and 181 
remained so during both the gastric and intestinal phase. The 60/40IF sample was turbid and 182 
white because of the intact casein micelles present in the dispersion but the 60/40hyd sample 183 
was more translucent as the casein present had been pre-hydrolysed. The control DWP and 184 
60/40IF whey protein dominant formulas became largely translucent at the end of the 185 
intestinal phase owing to the action of the intestinal enzymes. Significant differences were 186 
observed during the gastric digestion of SMP compared to SMPhyd. The images in Fig. 1 A 187 
show the SMP dispersion before digestion (in standard laboratory Petri dishes), which has a 188 
milk-white colour due to the presence of 80% casein in micellar form. In contrast to this, the 189 
hydrolysed form of SMP is more translucent (Fig. 1 D) due to the pre-digestion of caseins, 190 
which destabilises the casein micelle and reduces the turbidity. The SMP sample was 191 
observed to curdle after 5 min of gastric digestion due to protein aggregation induced by the 192 
change in pH to 5.3 and the action of pepsin. However, no curdling was observed in the 193 
SMPhyd sample throughout the gastric digestion (Fig. 1 E and F). After 60 min of gastric 194 
digestion the SMP sample contained a greater amount of visibly aggregated material (Fig. 1 195 
C) compared to the equivalent hydrolysed sample (Fig. 1 F). These differences between SMP 196 
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and SMPhyd disappeared during intestinal digestion due to the rapid action of pancreatic 197 
enzymes, and both digested samples appeared translucent (not shown). 198 
 199 
 200 
3.2 Protein profile 201 
Digested protein products were analysed by SEC-HPLC, whereby water-soluble proteins and 202 
peptides are separated by size and grouped into size intervals, see Fig. 2. Results can be 203 
correlated to the extent of proteolysis into small and medium peptides. From the SEC data a 204 
number of differences were observed between the control and hydrolysed samples for the 205 
gastric phase. When the molecular weight profiles (Fig. 2 A, B and C) for the samples before 206 
digestion (G0), were compared to the profiles from the gastric samples after 30 min (G30) 207 
and 60 min (G60) of digestion, clear differences were observed. In the control SMP samples 208 
(Fig. 2 A), the proportion of the two largest molecular weight materials (>30 kDa and 20-30 209 
kDa), which are associated to intact proteins and aggregates, decreased significantly (p<0.05) 210 
as gastric digestion progressed. Conversely, the proportion of the smaller molecular weight 211 
(1-5 kDa and <1 kDa) material increased significantly (p<0.05) during gastric digestion. The 212 
molecular weight profiles of SMPhyd were largely unaffected over the same time, except for 213 
some significant (p<0.05) differences in the 5-10 kDa material. Overall, there was a 214 
significantly (p<0.05) higher proportion of low molecular weight material (<1 kDa) in the 215 
SMPhyd samples in comparison to its corresponding control SMP. The proportion of small 216 
molecular weight material (1-5 kDa and <1 kDa) in both SMPhyd and SMP increased 217 
significantly (p<0.05) during intestinal digestion in comparison to the gastric phase, mainly 218 
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due to the efficient action of the pancreatic proteases including trypsin and chymotrypsin 219 
(Guo, Fox, Flynn, & Kindstedt, 1995; Tunick, et al., 2016). 220 
The whey proteins in the control DWP samples (Fig. 2 B) largely resisted gastric proteolysis 221 
and no changes were observed in their molecular weight profiles. In DWPhyd samples the 222 
proportion of the largest material (>30 kDa) decreased significantly (p<0.05) during the 223 
gastric phase. Comparing DWP and DWPhyd, there was significantly (p<0.05) more low 224 
molecular weight material (<1.0 kDa) present in the pre-hydrolysed DWPhyd throughout the 225 
gastric phase. There was a significantly (p<0.05) greater proportion of small (<1 kDa) 226 
molecular weight material in both the hydrolysed and control DWP samples after intestinal 227 
digestion (I15, I30 and I60) in comparison to the gastric samples (G30 and G60) as well as 228 
G0.  229 
A small but significant (p<0.05) decrease in the proportion of the high (>30 kDa) molecular 230 
weight material in the 60/40hyd (Fig. 2 C) after both 30 and 60 minutes gastric digestion, was 231 
observed when compared with the undigested sample (G0). There was no significant increase 232 
or decrease in the proportion of the different molecular weight materials after 30 and 60 min 233 
gastric digestion of the 60/40IF when compared to the sample prior to digestion (G0). 234 
There was a significantly (p<0.05) greater proportion of small (<1 kDa) molecular weight 235 
material in both 60/40IF and 60/40hyd after intestinal digestion (I15, I30 and I60) in 236 
comparison to their respective gastric samples (G30, G60 and G0).  237 
The percentage of <1 kDa molecular weight material in both the DWP and DWPhyd samples 238 
for the gastric phase appeared to be lower than the SMP and SMPhyd samples (Fig. 2 B and 239 
C). This is probably related to the higher percentage of casein present in the SMP, which is 240 
preferentially hydrolysed by pepsin, whereas the major whey proteins β-lg and α-lactalbumin 241 
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(α-lac), are known to resist or delay, but not prohibit the proteolysis by pepsin, mainly due to 242 
the compact native globular structure of the whey proteins (de Oliveira, et al., 2016; de 243 
Oliveira, et al., 2017; Sanchón, et al., 2018; Sullivan, Mok, & Brodkorb, 2013). 244 
3.3 Protein identification by SDS-PAGE 245 
The proteolytic action of both the gastric and intestinal enzymes can be clearly seen in the 246 
SDS-PAGE gel electrograms (Fig. 3 A, B and C). There are three bands apparent between 247 
20-30 kDa in the un-digested G0 sample for SMP, corresponding to the three major casein 248 
groups α, β and κ-Casein, and two bands for the whey proteins β-lg at ~18kDa α-lac at 249 
~14kDa. After 30 minutes of gastric digestion (G30) there is a clear decrease of the casein 250 
bands in comparison with G0, with a further diminution in intact protein observed at G60. 251 
The whey proteins in the SMP remained largely intact throughout gastric digestion. No bands 252 
corresponding to either intact casein or whey proteins were observed in the SMPhyd (Fig. 3 253 
A). 254 
The SDS-PAGE of DWP (Fig 3 B) clearly show the bands corresponding to intact α-lac and 255 
β-lg, which remain unchanged during the gastric phase. For the DWPhyd samples faint bands 256 
of both whey proteins, which decrease in intensity during the gastric phase are visible. 257 
However, no whey proteins bands of DWP and DWPhyd are detected during the intestinal 258 
phase. 259 
The SDS-PAGE electrograms of 60/40 IF (Fig. 3 C) displayed differences between the casein 260 
bands for G0, G30 and G60. G0 has three bands corresponding to α, β and κ-Caseins, 261 
whereas G30 and G60 have only fainter casein bands. The intensity of the bands 262 
corresponding to the whey proteins are not reduced upon gastric digestion. For the 60/40hyd 263 
there are no intact casein bands present and the faint whey protein bands are again reduced 264 
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during gastric digestion. No bands for casein or whey proteins appear in the intestinal digests 265 
except those of the digestive enzymes. 266 
3.4 Estimation of protein digestion  267 
The estimation of the protein digestion or percentage of digestibility was based on the 268 
quantification of TCA-soluble protein/peptides material (Calsamiglia & Stern, 1995; Rudloff 269 
& Lönnerdal, 1992), i.e. the TCA-soluble fraction in digested samples compared to the 270 
estimated protein in the original samples using the Kjeldahl method and a NCF of 6.38. The 271 
protein material coming from the enzyme extracts (pepsin and pancreatin) in blank 272 
experiments were deducted from quantified proteins in the digested samples. Only small 273 
peptides and amino acids remain soluble in 12% TCA (Yvon, Chabanet, & Pélissier, 1989) 274 
hence its use as an estimation of bioaccessible peptides and amino acids.  275 
The hydrolysed and un-hydrolysed SMP, DWP and 60/40IF samples were prepared and 276 
analysed in triplicate (n=3). As expected, the hydrolysed products SMPhyd, DWPhyd and 277 
60/40hyd (Table 2) have high proportions of TCA-soluble protein material i.e. 87, 49 and 278 
64%, respectively. Un-hydrolysed SMP, DWP and 60/40IF also contain TCA-soluble protein 279 
material i.e. 2.4, 4.7 and 4.2%, respectively. The Kjeldahl nitrogen results include small 280 
amounts of free amino acids and non-protein nitrogen, which amount to approximately 1% in 281 
milk and SMP (Lindmark-Månsson, Fondén, & Pettersson, 2003; McDermott, et al., 2016). 282 
Due to the manufacture of whey proteins, this proportion is expected to be higher in both 283 
DWP and 60/40IF. However, the effect of the initial NPN and free amino acids on the protein 284 
content in the TCA-soluble fraction is reduced upon progression of proteolysis during GI 285 
digestion. The data in Table 2 show that the gastric sample after 60 min (G60) for the SMP 286 
has a greater digestibility at 8.73% than G0 at 2.37%. The same trend was observed for the 287 
both DWP and 60/40IF sample, with digesta at G60 having significantly higher (p<0.05) 288 
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TCA-soluble protein material in comparison to those at G30 and G0. When comparing the 289 
same gastric time points of the ingredients together, significant differences were observed. 290 
The SMPhyd samples had a significantly (p<0.05) higher digestibility at G30 and G60 (88.4 291 
and 83.9%, respectively) than the same gastric digestion time points for the DWPhyd sample 292 
(44.1 and 46.2%, respectively). Similar trends were observed for both DWP vs. DWPhyd and 293 
60/40IF vs. 60/40hyd during gastric digestion. It was also noted that based on the TCA-294 
solubility, hydrolysed protein products were largely unaffected by gastric digestion, except 295 
for some significant (p<0.05) difference for SMPhyd at G60. 296 
When looking at the intestinal digestions at the I15, I30 and I60 time points (Table 2) there 297 
did not appear to be significant differences in digestibility for the hydrolysed or non-298 
hydrolysed samples i.e. the large differences observed for the gastric phase were negated in 299 
the intestinal digestion phase. 300 
 301 
3.5 Free amine determination by o-phthaldialdehyde assay (OPA) 302 
The OPA assay quantifies the relative amount of free amine groups liberated due to the 303 
cleavage of peptide bonds, and is therefore suitable indicator for the extent of proteolysis. 304 
OPA results are largely in line with all other results presented in this study. All gastric 305 
samples (Fig. 4) both before (G0) and after 30 and 60 min (G30 and G60) digestion had 306 
significantly (p<0.05) lower levels of free amine groups than the samples which had 307 
undergone intestinal digestion (I15, I30 and I60). The gastric samples of SMP, DWP and 308 
60/40IF contained significantly (p<0.05) lower amounts of free amine groups in comparison 309 
to SMPhyd, DWPhyd and 60/40hyd due to pre-digestion of these samples. 310 
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There was a significantly lower amount (p<0.05) of free amine groups in G0 of both the SMP  311 
and SMPhyd than after both 30 and 60 min gastric digestion when the gastric time points 312 
were compared together. This trend was repeated for the DWP and 60/40IF gastric samples. 313 
The intestinal samples (I15, I30 and I60) were not significantly different from one another 314 





4. Discussion  320 
The results of the study undertaken here show that pre-hydrolysing proteins appeared to aid 321 
the speed of gastric digestion of both the protein ingredients (SMPhyd, DWPhyd) as well as 322 
the resulting first stage infant protein formula (60/40hyd) when compared to their non-323 
hydrolysed counterparts. This is simply due to the hydrolysed proteins having a head-start in 324 
proteolysis during gastric digestion. After intestinal digestion the differences in digestibility, 325 
based on the TCA-soluble Kjeldahl protein nitrogen and free amine group analysis, 326 
disappeared completely. 327 
From the SEC data it could be seen that the hydrolysed SMP had a greater proportion of 328 
smaller molecular weight material (<1 kDa) and lower proportion of higher molecular weight 329 
material (20-30 and > 30 kDa) than the non-hydrolysed SMP, throughout the gastric phase. 330 
This was due to the cleavage of both the caseins and whey proteins by the proteolytic action 331 
of commercial enzymes, which had hydrolysed the proteins more effectively than the pepsin 332 
in the gastric phase. This is supported by the SDS-PAGE gels, which show a complete 333 
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hydrolysis of the casein and indeed whey protein bands in the SMPhyd samples and to a 334 
lesser extent the partial hydrolysis of the β-lg and α-lac in both the DWPhyd and 60/40hyd 335 
samples.  336 
The intact β-lg and α-lac of SMP, DWP and 60/40IF (Fig. 3) are not degraded to proteolytic 337 
products by gastric digestion alone as seen in the SDS-PAGE. The finding that the whey 338 
proteins in particular are more resistant to the action of the gastric enzymes concurs with the 339 
earlier findings of infant in vitro (de Oliveira, et al., 2016) and adult in vivo (Sanchón, et al., 340 
2018) studies. 341 
It is interesting to note that the remaining intact whey proteins in DWPhyd are hydrolysed by 342 
pepsin due to the commonly used industrial practice of heat-inactivation of the commercial 343 
enzymes after hydrolysis, which causes irreversible denaturation and aggregation of the whey 344 
proteins β-lg and α-lac. Unfolding and in particular aggregation of whey proteins has been 345 
shown to increase enzyme accessibility, which can accelerate its degradation (O’Loughlin, 346 
Murray, Kelly, FitzGerald, & Brodkorb, 2012). The SDS-PAGE and SEC data for the 347 
intestinal digestion showed a complete degradation of the SMP, DWP and IMF samples 348 
irrespective of whether they had been pre-hydrolysed or not. This is not surprising as 349 
pancreatic enzymes, trypsin and chymotrypsin in particular, are strong proteolytic enzymes 350 
(Kim, et al., 2007). 351 
Hydrolysed proteins in nutritional infant products are generally used for the purpose of 352 
avoiding or reducing the allergenicity of intact proteins (Alles, Scholtens, & Bindels, 2004; 353 
Zeiger, Heller, Mellon, O'Connor, & Hamburger, 1986) and the degradation of allergenic 354 
epitopes (Chobert, 2012). The current study presents evidence in vitro that the hydrolysis of 355 
protein products can reduce or prevent protein coagulation in the gastric phase, in particular for 356 
SMP but also 60/40IF. The coagulation observed in the static in vitro digestions is a result of 357 
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pepsin digestion at a constant pH of 5.3. Under physiological conditions, the pH is gradually 358 
lowered to pH 3-3.5 with increasing pepsin addition. This is likely to result in an even stronger 359 
protein coagulation due to the longer time frame of gelation, compared to the sudden drop in 360 
pH experienced in the static models. This effect could be simulated in dynamic or semi-361 
dynamic models (de Oliveira, et al., 2015; Mulet-Cabero, Torcello-Gómez, et al., 2020; Mulet, 362 
et al., 2019; Ye, et al., 2019). The coagulation observed for the SMP sample at pH 5.3 was 363 
probably due to two factors namely, the partial proteolysis of the caseins by pepsin, which can 364 
retain activity up to pH 5.5 (Piper & Fenton, 1965) and a concomitant pH induced coagulation 365 
of the SMP as observed in previous studies (Lucey, Teo, Munro, & Singh, 1997; Lucey, 366 
Tamehana, Singh, & Munro, 1998). Huppertz & Lambers (2020) recently suggested that the 367 
micellar calcium phosphate content also influenced the gastric coagulation behaviour of infant 368 
formula in vitro. The gastric transit i.e. (i) feeding, (ii) gastric restructuring by pH, enzymatic 369 
hydrolysis and peristalsis and (iii) gastric emptying into the duodenum are key factors in the 370 
overall kinetics of protein digestion. Pepsin is thought to act on milk in a similar manner as 371 
chymosin, which hydrolyses the Phe105 – Met106 peptide bond of -casein during cheese 372 
manufacture releasing caseinomacropeptide (CMP) and causing the milk to coagulate 373 
(Hooydonk, Olieman, & Hagedoorn, 1984). The gastric coagulation of protein can be 374 
modulated by pre-treatments such as heating, by formulation (Mulet-Cabero, Rigby, et al., 375 
2020) or by enzymatic hydrolysis of the proteins as demonstrated in this study. Differences in 376 
the physical properties of the coagulum have been shown to affect the kinetics of gastric 377 
emptying, appetite, satiety and feeling of fullness (Mackie, Rafiee, Malcolm, Salt, & van Aken, 378 
2013; Mulet-Cabero, Rigby, et al., 2020); liquid gastric contents are emptied easier and faster. 379 
The ease of digestion for infant formulations is thought to be important for the growing infant 380 
from the viewpoint of both abdominal discomfort as well as nutritional uptake and bio-381 
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accessibility (Boirie, et al., 1997; Gan, Bornhorst, Henrick, & German, 2018). Clinical trials 382 
with adults as well as studies using dynamic or semi-dynamic digestion methods seem to point 383 
towards gastric restructuring as a cause for changes in overall digestive kinetics and gastric 384 
emptying in particular. Only a small number of in vivo infant studies have correlated the use of 385 
hydrolysed proteins with gastric emptying kinetics. Mihatsch et al. (2001) observed with 386 
preterm infants (n = 15) that hydrolysed protein formula (75 % of the protein was smaller than 387 
1,500 Da) resulted in a significantly (p < 0.0022) shorter total gastro-intestinal transit time (9.8 388 
h) compared to standard preterm formula containing intact proteins (19 h). In a later study 389 
Mihatsch et al. (2005) proposed that the pre-hydrolysis of casein reduces the opioid activity of 390 
some peptides released from intact caseins during GI digestion with adult rats thereby 391 
accelerating total GI transit compared to intact caseins. Another study using the adult rat model 392 
(n = 8 to 15) showed that the gastric emptying time measured by x-ray was unaffected by the 393 
pre-hydrolysis of caseins whereas the whey proteins emptied faster than both hydrolysed whey 394 
proteins and caseins (Dalziel, Young, McKenzie, Haggarty, & Roy, 2017). An extensively 395 
hydrolysed formula (88% of the protein smaller than 1,500 Da) showed a significantly (p < 396 
0.05) faster gastric emptying time in healthy newborns (n = 20, measured by breath 
13
C-397 
octanoic acid) compared to both intact protein formula and partially hydrolysed formula 398 
(Staelens, et al., 2008); however no details on the extent of hydrolysis of the latter product 399 
were provided in the paper. The authors concluded that IF with extensively hydrolysed proteins 400 
may be better tolerated by infants with gastric emptying problems. An international working 401 
group consensus on the recommendation of partially hydrolysed formula concluded that 402 
“partially hydrolysed whey based formula is likely to result in faster gastric emptying than 403 
formula based on intact protein, but the clinical relevance, for instance with respect to gastric 404 
digestion, of this finding has not been demonstrated in term infants” (Vandenplas, et al., 2016). 405 
Median gastric emptying time as measured by real-time ultrasonography in preterm infants 406 
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(triple-blind, controlled trial) was significantly (p ≤ 0.018) faster using extensively hydrolysed 407 
formula compared to control formula (Baldassarre, et al., 2019). Other benefits of hydrolysed 408 
protein formula include the reduction in oesophageal acid exposure in preterm infants 409 
(gestational age ≤ 33 week, randomised crossover trial) with feeding intolerance and symptoms 410 
of gastro-oesophageal reflux (Corvaglia, Mariani, Aceti, Galletti, & Faldella, 2013). 411 
Hydrolysed whey proteins in combination with higher concentration sn-2 palmitic acid and 412 
prebiotic oligosaccharides resulted in a strong tendency (but no statistical significance) of 413 
softer stools in constipated infants (n = 35, randomised crossover trial). Hence, to date there is 414 
no clear consensus on the matter, even though some results point towards a shorter digestion 415 
time, which is generally associated with easier digestion. However, most clinical studies with 416 
hydrolysed protein formulas were conducted using relatively small numbers of infants 417 
compared to larger studies (Alarcon, Tressler, Mulvaney, Lam, & Comer, 2002) correlating 418 
protein re-formulation (e.g. caseins vs. whey proteins enriched formula) with changes in the 419 
gastric emptying, among others (n=6,999 in 17 countries). Many clinical studies also fall short 420 
of correlating the molecular or micro-structural changes with the mechanism and kinetics of GI 421 
digestion. More invasive techniques such as neonatal naso-gastric aspiration (de Oliveira, et al., 422 
2017) in combination with in vitro digestion studies are necessary for any meaningful 423 
correlation to be drawn between the food, digestion and health, though such in vivo studies 424 
have clear ethical limitations as regards to risk vs. benefit and fewer and fewer studies are 425 
currently being conducted. 426 
For the protein products presented in this study, it is reasonable to assume that hydrolysed 427 
proteins are emptied faster than products containing intact proteins. This might aid their ease of 428 
digestion, based on some of the in vivo studies mentioned above, and thus help to reduce some 429 
symptoms of discomfort. More sophisticated digestion models such as the consensus semi-430 
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dynamic models (Mulet-Cabero, Egger, et al., 2020) can also be applied to study gastric 431 
coagulation behaviour more accurately (Mulet-Cabero, Torcello-Gómez, et al., 2020). Efforts 432 
within the research community, such as the INFOGEST network, are being made to agree on 433 
an acceptable consensus on digestion methods for population groups such as infants (Levi, et 434 
al., 2017). 435 
 436 
5. Conclusions 437 
Infant in vitro digestion of protein ingredients and model infant formula provide a good 438 
insight into the mechanism of protein digestion. The results of the study showed that pre-439 
treatment such as partial hydrolysis of proteins can accelerate the gastric digestion of proteins 440 
in ingredients and model infant protein formulations compared to the equivalent non-441 
hydrolysed, samples containing whole proteins. This is particularly true when comparing the 442 
protein and peptide pattern at the end of the gastric phase, where pre-treated proteins already 443 
exhibited a higher degree of proteolysis even prior to digestion. The final digestion product 444 
after intestinal digestion seemed largely unaffected by pre-treatment. From the SDS-PAGE 445 
data it also appeared that the gastric enzymes acted faster on α-lac than β-lg, which correlates 446 
well with available in vivo data. The information of this study could be used to help design 447 
formula, which would have lower GI transit times and help design easier to digest formula for 448 
infants where breastfeeding is not an option. 449 
 450 
  451 
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 654 
Table 1: Average compositional analysis of powders for trials  standard deviation. 655 
 Protein % Fat % Lactose % Moisture % Ash % 
SMP 35.9 ± 0.09 0.71 ± 0.07 51.3 ± 0.03 4.40 ± 0.02 7.74 ± 0.01 
SMPhyd 35.3 ± 0.09 0.76 ± 0.21 57.0 ± 0.28 2.55 ± 0.24 4.31 ± 0.58 
DWP 12.2 ± 0.02 0.80 ± 0.02 84.3 ± 10.1 2.06 ± 0.03 0.65 ± 0.08 
DWPhyd 12.9 ± 0.01 0.93 ± 0.13 82.7 ± 0.25 2.09 ± 0.02 1.35 ± 0.09 
60/40IF 19.2 ± 0.21 0.99 ± 0.04 74.1 ± 0.17 2.21 ± 0.04 3.47 ± 0.01 




Table 2: Protein content of the TCA-soluble fraction determined by the Kjeldahl method (NCF 659 
6.38) before, during and after in vitro digestion: gastric time points G0, G30 and G60 and intestinal 660 
time points I15 and I60 for SMP, DWP and 60/40IF in comparison to corresponding time points for 661 
pre-hydrolysed samples SMPhyd, DWPhyd and 60/40hyd, respectively. Lower case letters denote 662 
significant differences across rows, while upper case letters denote significant differences between 663 
means down columns (n = 3). 664 










































 83.3±2.34 88.0±6.69 82.2±9.46 
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 667 
Fig. 1: Example images of digestion of SMP and SMPhyd using static in vitro digestion: 668 
SMP reconstituted at 2% (w/w) protein before digestion (A), after 5 min gastric digestion (B) 669 
and after 60 min gastric digestion (C); SMPhyd reconstituted at 2% (w/w) protein before 670 
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Fig. 2: Molecular weight distribution as determined by size exclusion HPLC of the soluble proteins 678 
and peptides; <1 kDa ( ▬ ),  1-5 kDa ( ▬ ), 5-10 kDa ( ▬ ), 10-20 kDa( ▬ ), 20-30kDa ( ▬ ), >30 679 
kDa ( ▬ ) of digesta from in vitro static digestion of (A) skim milk (SMP) compared to hydrolysed 680 
skim milk (SMPhyd), (B) demineralised whey (DWP) compared to hydrolysed demineralised whey 681 
(DWPhyd) and (C) an infant formula protein blend with a 60/40 whey protein to casein ratio 682 
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 692 
Fig. 3:  SDS-PAGE protein profiles of static digestion of (A) skim milk (SMP) compared to 693 
hydrolysed skim milk (SMPhyd); (B) demineralised whey (DWP) compared to hydrolysed 694 
demineralised whey (DWPhyd) and (C) an infant formula protein blend with a 60/40 whey 695 
protein to casein ratio (60/40IF) compared to the hydrolysed equivalent (60/40hyd). 696 
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 698 
 699 
Fig. 4: Concentration of free amine groups in μmol per g of protein as determined by OPA 700 
assay: Comparison of digesta of SMP, DWP and 60/40IF to SMPhyd, DWPhyd and 701 
60/40hyd in the gastric phase at time G0 ( ), G30 ( ), G60 ( ) and intestinal phase at 702 
time I15 ( ), I30 ( ) and I60 ( ). Mean values within a column with different 703 
uppercase letters (A, B, C) were significantly different (p <0.05), comparison was between 704 
gastric time points only. 705 
 706 
